Abstract
Monoclonal antibody drugs have become a large portion of protein therapeutics and many antibody molecules are being evaluated at various stages of clinical trials in the biopharmaceutical industry. This review article summarizes the state of the art antibody purification techniques. The main focus is chromatographic techniques that include protein A, ion exchange and HIC. For each technique, the mechanisms of antibody binding, factors affecting binding capacity, resin selection, as well as typical process parameters and chromatograms are discussed in detail. Cell culture clarification, filtration, alternative antibody purification techniques, and viral clearance strategies are discussed briefly. The goal of this article is to provide a broad coverage of antibody purification technology. Readers are referred to extensive articles for further in-depth reading.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arakawa, T., Philo, J. S., Tsumoto, K., Yumioka, R. & Ejima, D. (2004) Elution of antibodies from a Protein-A column by aqueous arginine solutions. Protein Expr Purif, 36, 244–248.
Blank, G. S., Zapata, G., Fahrner, R., Milton, M., Yedinak, C., Knudsen, H. & Schmelzer, C. (2001) Expanded bed adsorption in the purification of monoclonal antibodies: a comparison of process alternatives. Bioseparation, 10, 65–71.
Boi, C. (2007) Membrane adsorbers as purification tools for monoclonal antibody purification. J Chromatogr B Analyt Technol Biomed Life Sci, 848, 19–27.
Braisted, A. C. & Wells, J. A. (1996) Minimizing a binding domain from protein A. Proc Natl Acad Sci USA, 93, 5688–5692.
Bronson, K. (2007) Advances in viral clearance. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Burton, D. R. (1985) Immunoglobulin-G – functional sites. Mol Immunol, 22, 161–206.
Burton, S. C. & Harding, D. R. (1998) Hydrophobic charge induction chromatography: salt independent protein adsorption and facile elution with aqueous buffers. J Chromatogr A, 814, 71–81.
Chu, L. & Robinson, D. K. (2001) Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol, 12, 180–187.
Coffman, J., Shpritzer, R. & Vicik, S. (2006) Flocculation of antibody-producing mammalian cells with precipitating solutions of soluble cations and anions. Recovery of biological products XII. Litchfield, AZ.
Deisenhofer, J. (1981) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry, 20, 2361–2370.
Fahrner, R. L., Knudsen, H. L., Basey, C. D., Galan, W., Feuerhelm, D., Vanderlaan, M. & Blank, G. S. (2001) Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes. Biotechnol Genet Eng Rev, 18, 301–327.
Fiore, J. V., Olson, W. P. & Holst, S. L. (1980) Depth filtration. In Curling, J. M., (Ed.) Methods of plasma protein fractionation. New York City, NY, Academic Press.
Fraud, N., Faber, R., Kiss, C., Demmer, W., Hoerl, H. -H. & Fischer-Fruehholz, S. (2009) Hydrophobic-interaction membrane chromatography for large-scale purification of biopharmaceuticals. BioProcess Int, 7, 30–35.
Gagnon, P. (1996) Purification tools for monoclonal antibodies. Tucson, AZ, Validated Biosystems.
Gagnon, P. (2009) Purification of monoclonal antibodies by mixed-mode chromatography. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, Wiley
Ghose, S., Allen, M., Hubbard, B., Brooks, C. & Cramer, S. M. (2005) Antibody variable region interactions with Protein A: implications for the development of generic purification processes. Biotechnol Bioeng, 92, 665–673.
Ghose, S., Hubbard, B. & Cramer, S. M. (2006) Evaluation and comparison of alternatives to Protein A chromatography – mimetic and hydrophobic charge induction chromatographic stationary phases. J Chromatogr A, 1122, 144–152.
Ghose, S., Jin, M., Liu, J. & Hickey, J. (2009) Integrated polishing steps for monoclonal antibody purification. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, Wiley.
Ghose, S., Mcnerney, T. M. & Hubbard, B. (2002) pH Transitions in ion-exchange systems: role in the development of a cation-exchange process for a recombinant protein. Biotechnol Prog, 18, 530–537.
Ghose, S., Mcnerney, T. & Hubbard, B. (2007) Protein A affinity chromatography for capture and purification of monoclonal antibodies and Fc-Fusion Proteins: practical considerations for process development. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Giovannoni, L., Ventani, M. & Gottschalk, U. (2009) Antibody purification using membrane adsorbers. Biopharm Int, 28–32.
Gorbunoff, M. J. (1984a) The interaction of proteins with hydroxyapatite. 1. Role of protein charge and structure. Anal Biochem, 136, 425–432.
Gorbunoff, M. J. (1984b) The interaction of proteins with hydroxyapatite. 2. Role of acidic and basic groups. Anal Biochem, 136, 433–439.
Gorbunoff, M. J. & Timasheff, S. N. (1984) The interaction of proteins with hydroxyapatite. 3. Mechanism. Anal Biochem, 136, 440–445.
Gottschalk, U. (2008) Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnol Prog, 24, 496–503.
Gulich, S., Uhlen, M. & Hober, S. (2000) Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography. J Biotechnol, 76, 233–244.
Hahn, R., Schlegel, R. & Jungbauer, A. (2003) Comparison of protein A affinity sorbents. J Chromatogr B Analyt Technol Biomed Life Sci, 790, 35–51.
Hale, G., Drumm, A., Harrison, P. & Phillips, J. (1994) Repeated cleaning of protein-a affinity column with sodium-hydroxide. J Immunol Methods, 171, 15–21.
Harinarayan, C., Mueller, J., Ljunglof, A., Fahrner, R., Van Alstine, J. & Van Reis, R. (2006) An exclusion mechanism in ion exchange chromatography. Biotechnol Bioeng, 95, 775–787.
Hjelm, H., Sjodahl, J. & Sjoquist, J. (1975) Immunologically active and structurally similar fragments of protein-a from staphylococcus-aureus. Eur J Biochem, 57, 395–403.
Jagschies, G., Gronberg, A., Bjorkman, T., Lacki, K. & Johansson, H. J. (2006) Technical and economical evaluation of downstream processing options for monoclonal antibody (MAb) production. Biopharm Int June Suppl., 10–19.
Jefferis, R. (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog, 21, 11–16.
Kawasaki, T. (1991) Hydroxyapatite as a liquid-chromatographic packing. J Chromatogr, 544, 147–184.
Kelley, B. (2007) Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog, 23, 995–1008.
Kelley, B., Blank, G. & Lee, A. (2009) Downstream processing of monoclonal antibodies: current practices and future opportunities. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, John Wiley & Sons, Inc.
Kelley, B. D., Tobler, S. A., Brown, P., Coffman, J. L., Godavarti, R., Iskra, T., Switzer, M. & Vunnum, S. (2008) Weak partitioning chromatography for anion exchange purification of monoclonal antibodies. Biotechnol Bioeng, 101, 553–566.
Kennedy, R. M. (1990) Hydrophobic chromatography. Methods Enzymol, 182, 339–357.
Kinolov, Z. L., Regan, J. T., Dickey, L. F. & Woodard, S. L. (2009) Purification of antibodies from transgenic plants. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, Wiley.
Knight, R. & Ostreicher, E. (1998) Charge-modified filter media. In Meltzer, T. H., Jornitz, M. W., (Eds.) Filtration in the biopharmaceutical industry. New York, NY, Marcel Dekker.
Knudsen, H. L., Fahrner, R. L., Xu, Y., Norling, L. A. & Blank, G. S. (2001) Membrane ion-exchange chromatography for process-scale antibody purification. J Chromatogr A, 907, 145–154.
Kundu, A. & Reindel, K. (2007) Evaluation of viral clearance in purification processes. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Lajmi, A., Kutner, R. & Reiser, J. (2007) A membrane chromatography application: a rapid, high capacity gene therapy vector purification tool. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Lee, S. S., Burt, A., Russotti, G. & Buckland, B. (1995) Microfiltration of recombinant yeast-cells using a rotating-disk dynamic filtration system. Biotechnol Bioeng, 48, 386–400.
Li, R., Dowd, V., Stewart, D. J., Burton, S. J. & Lowe, C. R. (1998) Design, synthesis, and application of a Protein A mimetic. Nat Biotech, 16, 190–195.
Lindmark, R., Movitz, J. & Sjoquist, J. (1977) Extracellular protein-a from a methicillin-resistant strain of staphylococcus-Aureus. Eur J Biochem, 74, 623–628.
Low, D., O’leary, R. & Pujar, N. S. (2007) Future of antibody purification. J Chromatogr B Analyt Technol Biomed Life Sci, 848, 48–63.
Lu, Y., Williamson, B. & Gillespie, R. (2009) Recent advancement in application of hydrophobic interaction chromatography for aggregate removal in industrial purification process. Curr Pharm Biotechnol, 10, 427–433.
Luan, Y. T., Wang, W., Nolan, R. & Drapeau, D. (2006) Defined medium development for high yielding mammalian cell culture processes. IBC & Bioprocess International conference. San Francisco, CA.
Lydersen, B. K., Brehm-Gibson, T. & Murel, A. (1994) Acid precipitation of mammalian cell fermentation broth. Ann NY Acad Sci, 745, 222–231.
Mccue, J. T., Kemp, G., Low, D. & Quinones-Garcia, I. (2003) Evaluation of protein-A chromatography media. J Chromatogr A, 989, 139–153.
Miesegaes, G., Lute, S. & Brorson, K. (2010) Analysis of viral clearance unit operations for monoclonal antibodies. Biotechnol Bioeng, 106, 238–246.
Moks, T., Abrahmsen, L., Nilsson, B., Hellman, U., Sjoquist, J. & Uhlen, M. (1986) Staphylococcal protein-a consists of 5 Igg-binding domains. Eur J Biochem, 156, 637–643.
Queiroz, J. A., Tomaz, C. T. & Cabral, J. M. (2001) Hydrophobic interaction chromatography of proteins. J Biotechnol, 87, 143–159.
Riske, F., Schroeder, J., Belliveau, J., Kang, X., Kutzko, J. & Menon, M. K. (2007) The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery. J Biotechnol, 128, 813–823.
Rohrbach, P., Broders, O., Toleikis, L. & Dubel, S. (2003) Therapeutic antibodies and antibody fusion proteins. Biotechnol Genet Eng Rev, 20, 137–163.
Rosenberg, A. S. (2006) Effects of protein aggregates: an immunologic perspective. AAPS J, 8, E501–E507.
Russell, E., Wang, A. & Rathore, A. S. (2007) Harvest of a therapeutic protein product form high cell density fermentation broths: principles and case study. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Schwartz, W., Judd, D., Wysocki, M., Guerrier, L., Birck-Wilson, E. & Boschetti, E. (2001) Comparison of hydrophobic charge induction chromatography with affinity chromatography on protein A for harvest and purification of antibodies. J Chromatogr A, 908, 251–263.
Senczuk, A. M., Klinke, R., Arakawa, T., Vedantham, G. & Yigzaw, Y. (2009) Hydrophobic interaction chromatography in dual salt system increases protein binding capacity. Biotechnol Bioeng, 103, 930–935.
Shpritzer, R., Vicik, S., Orlando, S., Acharya, H. & Coffman, J. (2006) Calcium phosphate flocculation of antibody-producing mammalian cells at pilot scale. 232nd American chemical society national meeting. San Francisco, CA.
Shukla, A. A. & Han, X. S. (2007) Screening chromatographic stationary phases. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Shukla, A. A., Hinckley, P. J., Gupta, P., Yigzaw, Y. & Hubbard, B. (2005) Strategies to address aggregation during protein A chromatography. BioProcess Int, 3, 36–45.
Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S. & Low, D. (2007) Downstream processing of monoclonal antibodies–application of platform approaches. J Chromatogr B Analyt Technol Biomed Life Sci, 848, 28–39.
Shukla, A. A. & Kandula, J. R. (2009) Harvest and recovery of monoclonal antibodies: cell removal and clarification. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, Wiley.
Shukla, A. A. & Yigzaw, Y. (2007) Modes of preparative chromatography. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Smith, G. R. S. (1998) Filter aid filtration. In Meltzer, T. H., Jornitz, M. W., (Eds.) Filtration in the biopharmaceutical industry. New York City, NY, Marcel Dekker.
Sonnenfeld, A. & Thommes, J. (2007) Expanded bed adsorption for capture from crude solution. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Spitali, M. (2009) Downstream processing of monoclonal antibody fragments. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, John Wiley & Sons, Inc.
Staby, A., Sand, M. B., Hansen, R. G., Jacobsen, J. H., Andersen, L. A., Gerstenberg, M., Bruus, U. K. & Jensen, I. H. (2005) Comparison of chromatographic ion-exchange resins IV. Strong and weak cation-exchange resins and heparin resins. J Chromatogr A, 1069, 65–77.
Stein, A. & Kiesewetter, A. (2007) Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal. J Chromatogr B Analyt Technol Biomed Life Sci, 848, 151–158.
Terman, D. S. & Bertram, J. H. (1985) Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents. Eur J Cancer Clin Oncol, 21, 1115–1122.
Thommes, J. & Etzel, M. (2007) Alternatives to chromatographic separations. Biotechnol Prog, 23, 42–45.
Thommes, J. & Gottschalk, U. (2009) Alternatives to packed-bed chromatography for antibody extraction and purification. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, John Wiley & Sons, Inc.
Thommes, J. & Kula, M. R. (1995) Membrane chromatography – an integrative concept in the downstream processing of proteins. Biotechnol Prog, 11, 357–367.
Tipton, B., Boose, J. A., Larsen, W., Beck, J. & O’brien, T. (2002) Retrovirus and parvovirus clearance from an affinity column product using adsorptive depth filtration. Biopharm-Appl T Bio, 15, 43–50.
Van Reis, R., Leonard, L. C., Hsu, C. C. & Builder, S. E. (1991) Industrial scale harvest of proteins from mammalian cell culture by tangential flow filtration. Biotechnol Bioeng, 38, 413–422.
Van Reis, R. & Zydney, A. (2001) Membrane separations in biotechnology. Curr Opin Biotechnol, 12, 208–211.
Van Reis, R. & Zydney, A. (2007) Bioprocess membrane technology. J Memb Sci, 297, 16–50.
Vunnum, S., Vedantham, G. & Hubbard, B. (2009) Protein A-based affinity chromatography. In Gottschalk, U., (Ed.) Process scale purification of antibodies. Hoboken, NJ, John Wiley & Sons, Inc.
Walsh, G. (2004) Modern antibody-base therapeutics. BioPharm Int, 17, 18–25.
Wang, J., Diehl, T., Aguiar, D., Dai, X. P. & Arunakumari, A. (2009) Precipitation of process-derived impurities in non-protein A purification schemes for antibodies. Biopharm Int, 32, 4–10.
Yang, T., Malmquist, G., Johansson, B. L., Maloisel, J. L. & Cramer, S. (2007) Evaluation of multi-modal high salt binding ion exchange materials. J Chromatogr A, 1157, 171–177.
Yigzaw, Y., Piper, R., Tran, M. & Shukla, A. A. (2006) Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification. Biotechnol Prog, 22, 288–296.
Zeng, X. & Ruckenstein, E. (1999) Membrane chromatography: preparation and applications to protein separation. Biotechnol Prog, 15, 1003–1019.
Zhang, C. & Van Cott, K. E. (2007) Product recovery from transgenic sources. In Shukla, A. A., Etzel, M. R., Gadam, S., (Eds.) Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL, CRC Press.
Zhou, J. X. & Tressel, T. (2006) Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog, 22, 341–349.
Zhou, J. X., Tressel, T., Gottschalk, U., Solamo, F., Pastor, A., Dermawan, S., Hong, T., Reif, O., Mora, J., Hutchison, F. & Murphy, M. (2006) New Q membrane scale-down model for process-scale antibody purification. J Chromatogr A, 1134, 66–73.
Acknowledgements
The authors are grateful to Yinges Yigzaw at Amgen for his feedbacks during the preparation of the chapter. We also would like to thank Priyanka Gupta at Sartorius Stedim North America Inc. for the permission to use Fig. 14.9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Han, X., Hewig, A., Vedantham, G. (2011). Recovery and Purification of Antibody. In: Al-Rubeai, M. (eds) Antibody Expression and Production. Cell Engineering, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1257-7_14
Download citation
DOI: https://doi.org/10.1007/978-94-007-1257-7_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1256-0
Online ISBN: 978-94-007-1257-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)